GSK submits lupus drug for EU approval

06/7/2010 | Reuters

GlaxoSmithKline submitted a marketing application to the European Medicines Agency for its lupus drug candidate Benlysta. The drugmaker, which co-develops Benlysta with Human Genome Sciences, also plans to file for FDA approval of the treatment later this month.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN